BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 28000881)

  • 41. Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma.
    Gao J; Zou Z; Gao J; Zhang H; Lin Z; Zhang Y; Luo X; Liu C; Xie J; Cai C
    Int J Clin Exp Pathol; 2015; 8(1):345-52. PubMed ID: 25755721
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
    Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
    Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
    Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
    Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinoma.
    Chen YF; Ma G; Cao X; Huang ZL; Zeng MS; Wen ZS
    Med Oncol; 2014 Dec; 31(12):317. PubMed ID: 25377660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpressed PTOV1 associates with tumorigenesis and progression of esophageal squamous cell carcinoma.
    Li R; Leng AM; Liu XM; Hu TZ; Zhang LF; Li M; Jiang XX; Zhou YW; Xu CX
    Tumour Biol; 2017 Jun; 39(6):1010428317705013. PubMed ID: 28651486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TRPV6 plays a new role in predicting survival of patients with esophageal squamous cell carcinoma.
    Zhang SS; Xie X; Wen J; Luo KJ; Liu QW; Yang H; Hu Y; Fu JH
    Diagn Pathol; 2016 Jan; 11():14. PubMed ID: 26818094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Nakahara Y; Yamasaki M; Sawada G; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mimori K; Mori M; Doki Y
    Oncology; 2016; 90(6):347-55. PubMed ID: 27082627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
    Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang J; Yang Y; Chen L; Zheng D; Ma J
    Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma.
    Shirakawa M; Fujiwara Y; Sugita Y; Moon JH; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Mori M; Doki Y
    Oncol Rep; 2012 Apr; 27(4):940-6. PubMed ID: 22200953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
    Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
    Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
    Liu L; Yang Z; Ni W; Xuan Y
    Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.